Novo and Hims & Hers team up to sell branded GLP-1s, ending feud
4 days ago · Hims & Hers and Novo Nordisk have officially laid down their swords. After a longstanding public feud, the two companies have come to an agreement that will see Novo’s branded GLP-1 …
Hims & Hers partners with Novo Nordisk for GLP-1 sales
4 days ago · Telehealth company Hims & Hers on Monday announced a “strategic shift” in its business model, partnering with pharmaceutical company Novo Nordisk to sell its blockbuster GLP-1 medic…
Hims vs. Ro Weight Loss 2025: How Do They Compare?
Jul 3, 2025 · Zepbound ® Ozempic ® Wegovy ® Ro also offers access to Zepbound at a slightly reduced self-pay cost. How Much Weight Can You Lose With Hims vs. Ro? Both Hims and Ro offer …
Novo Nordisk Hims GLP-1 Deal: Pricing & Access - GLP Winner
1 day ago · Novo Nordisk and Hims struck a deal on Ozempic and Wegovy pricing. See what it means for GLP-1 costs, compounded access, and your options.
Hims & Hers Made a Surprising Concession to End Its GLP‑1 Beef With ...
4 days ago · Hims & Hers and Novo Nordisk’s very public eight-month-long feud over GLP-1 drugs just came to an end. Today, the two former rivals officially announced that they’re putting down their …
‘They Need Each Other’: Why Hims & Hers and Novo Nordisk Made Up
2 days ago · Novo Nordisk dropped its lawsuit against Hims & Hers and launched a new collaboration. The deal is advantageous for both companies, experts say.
Novo Nordisk Agrees To Sell GLP-1 Drugs Via Hims & Hers ... - BioSpace
4 days ago · Novo Nordisk has struck a deal to sell its injectable and oral GLP-1 medicines through telehealth provider Hims & Hers, ending a long-running dispute that recently triggered a lawsuit. …
Hims & Hers, Novo Nordisk strike GLP-1 partnership to end patent ...
3 days ago · Hims & Hers Health on Monday announced a collaboration with Novo Nordisk as part of a new strategy for weight-loss care treatments involving GLP-1 drugs. The agreement settles a patent …
Novo, Hims strike GLP-1 deal after legal feud
4 days ago · Novo Hims strike GLP-1 deal to expand FDA-approved weight loss medication access and end legal dispute over compounded drugs.
Hims & Hers Health will stop selling compound GLP-1 to settle lawsuit
4 days ago · Hims & Hers Health has agreed to stop selling compound versions of Wegovy, instead partnering with Novo Nordisk to sell its weight loss medications. (AP Photo)